4th Quarter - Report

RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

BIS-2025-0022 - Rare Disease Exemption for Pharmaceutical Tariffs CMS-5545-P - Rare Disease Exemption from GLOBE Model CMS-5546-P - Rare Disease Exemption from GUARD Model

LobbyistCovered position, as disclosed
YOKO ROSENBAUM —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

HR 1262 - Give Kids a Chance Act of 2025 S 932 - Give Kids a Chance Act of 2025 Rare Disease Exemption for Most Favored Nation Pricing Proposals

LobbyistCovered position, as disclosed
STACEY FRISK —
YOKO ROSENBAUM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 1262 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.